Aceso Life Science Scraps Major Share Subscription Deal, Cites Unmet ConditionsTip Ranks·Sep 17, 2026 at 01:08 PM004740.00%
Aceso Life Science Wins Unanimous Shareholder Backing for AGM ResolutionsTip Ranks·Sep 16, 2026 at 11:37 AM004740.00%
Aceso Life Science issues supplemental disclosure on FVTOCI investment valuations and impairmentsPUBT·Sep 11, 2026 at 02:33 PM004740.00%
Aceso Life Science Sets 2026 AGM to Renew Mandates and Expand Share Issuance AuthorityTip Ranks·Aug 20, 2026 at 09:42 AM004740.00%
Aceso Life Science seeks Hong Kong exchange trading resumption from Aug. 14PUBT·Aug 13, 2026 at 12:41 PM004740.00%
Aceso Life Science Swings to Annual Profit on Discontinued Operations GainTip Ranks·Aug 13, 2026 at 04:38 AM004740.00%
Aceso Life Science swings to FY26 profit of HK$336 million; revenue rises 16% to HK$58 millionPUBT·Aug 13, 2026 at 04:12 AM004740.00%
Aceso Life Science postpones shareholder circular, pushing EGM timetable to Sept. 30PUBT·Aug 5, 2026 at 01:56 PM004740.00%
Aceso Life Science Sets Board Date as Share Trading Remains Suspended Pending ResultsTip Ranks·Aug 3, 2026 at 02:41 PM004740.00%
Aceso Life Science expects FY profit of about HK$336 million vs HK$1.02 billion loss a year earlierPUBT·Aug 3, 2026 at 12:21 PM004740.00%
Aceso Life Science Delays Dispatch of Subscription Agreement Circular to ShareholdersTip Ranks·Jul 2, 2026 at 02:38 PM004740.00%
Aceso Life Science delays shareholder meeting circular dispatch to end-JulyPUBT·Jul 2, 2026 at 02:06 PM004740.00%
Aceso Life Science Delays 2026 Results, Faces Trading Suspension in Hong KongTip Ranks·Jul 2, 2026 at 01:08 AM004740.00%
